Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Calgary

$17,500.00

Disrupting P2X7 Receptor Phosphorylation Alleviates Neuropathic Pain

FY 2014-15

Summary
Neuropathic pain is a debilitating chronic pain condition that can arise after peripheral nerve damage caused by disease, infection, or physical injury. 2-3% of the general population, or roughly one million Canadians, suffers from neuropathic pain. The prevalence of this disabling condition, together with the lack of effective treatment options, underscores a pressing need for improved therapies. Converging evidence suggests that neuropathic pain is caused by aberrant cellular and molecular changes within the central nervous system (CNS). Our research will dissect the molecules and processes within the spinal cord that are critically involved in neuropathic pain. This proposal examines the inner workings of microglia, which are important immune cells in the CNS. We will focus on a molecule that is critical for microglia chronic pain signaling in the spinal cord – the P2X7 receptor – and the mechanisms that regulate its activity in the sequelae of neuropathic pain. By dissembling the cellular machinery of neuropathic pain, we can begin to target core components of this machinery to enhance current pain therapies or help create novel treatments for neuropathic pain sufferers.
Program
Master's Award: Canada Graduate Scholarships
Location
Alberta, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
331409
Name
Pilapil Alexandra N
Region
Alberta
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Disrupting P2X7 Receptor Phosphorylation Alleviates Neuropathic Pain
Programtype2
Studentship Programs
Orgnameinp2
University of Calgary
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Microglia; Neuropathic Pain; P2x7 Receptors; Spinal Cord
Abstract
Neuropathic pain is a debilitating chronic pain condition that can arise after peripheral nerve damage caused by disease, infection, or physical injury. 2-3% of the general population, or roughly one million Canadians, suffers from neuropathic pain. The prevalence of this disabling condition, together with the lack of effective treatment options, underscores a pressing need for improved therapies. Converging evidence suggests that neuropathic pain is caused by aberrant cellular and molecular changes within the central nervous system (CNS). Our research will dissect the molecules and processes within the spinal cord that are critically involved in neuropathic pain. This proposal examines the inner workings of microglia, which are important immune cells in the CNS. We will focus on a molecule that is critical for microglia chronic pain signaling in the spinal cord – the P2X7 receptor – and the mechanisms that regulate its activity in the sequelae of neuropathic pain. By dissembling the cellular machinery of neuropathic pain, we can begin to target core components of this machinery to enhance current pain therapies or help create novel treatments for neuropathic pain sufferers.
Competitiondate
201412
Approvedterm2
1 yr 0 mth
Pinamesdelim
Pilapil, Alexandra N
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~